Other real estate activities on a fee or contract basis
NORAMIX LIAMYRANE 12 AS
Revenue 2024
NOK 5.5m
Operating profit
NOK 3.1m
Equity
NOK 13.4m
Incorporated
2014
Share capital
NOK 790,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 5.5m | |
| Total operating costs | 2.4m | |
| Operating profit (EBIT) | 3.1m | |
| Net financial items | 92k | |
| Profit for the year | 2.5m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 18.2m | |
| of which current assets | 5.0m | |
| Equity | 13.4m | |
| Total liabilities | 4.8m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.